Clinical trial
Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors
NCT00093873 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00093873 |
|---|---|
| Title | Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors |
| Official title | A Phase 1, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects With Advanced Solid Tumors |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | Anti-angiogenesis, AMG 706 |
| Enrollment | 71 |
| Start date | Jul 1, 2003 |
| Primary completion | Feb 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 8, 2004 |
| Last update posted | May 15, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: